Governance

Corporate
Responsibility.

At Akman Pharma, corporate responsibility is deeply embedded in our purpose, shaping our strategy, governance, and day-to-day operations.

At Akman Pharma, corporate responsibility is deeply embedded in our purpose, shaping our strategy, governance, and day-to-day operations. We operate with an unwavering commitment to excellence, integrity, and accountability—principles that define our engagement with employees, partners, the medical community, patients, and society at large.

We are dedicated to creating sustainable value beyond compliance, consistently exceeding legal and regulatory expectations. Our responsibility extends across the entire healthcare ecosystem, reflecting a conscious and enduring commitment to all stakeholders impacted by our activities.

Responsibility in the Marketplace

Our approach to marketplace responsibility is guided by three strategic pillars:

A) Product Stewardship and Quality Excellence

We uphold the highest standards of quality and compliance throughout the entire lifecycle of our pharmaceutical products—from export and storage to distribution and commercialization.

Our commitment extends beyond supply chain integrity. We actively monitor the safety, performance, and real-world impact of our products, ensuring that patient safety and therapeutic effectiveness remain paramount at all times.

B) Trusted Partnerships Across the Healthcare Ecosystem

We believe that long-term value is built on trust, transparency, and scientific integrity. We cultivate enduring, responsible partnerships with all stakeholders across the healthcare landscape, including:

  • Healthcare professionals and the scientific community
  • Public health authorities and institutions
  • Distribution partners and customers
  • Suppliers and strategic collaborators
  • Patients and patient communities

Through ethical conduct and collaborative engagement, we strengthen a network built on shared responsibility and mutual trust.

C) Ethical and Scientific Engagement

Our communication and promotion of prescription medicines are conducted with the highest ethical standards and in full compliance with international and national regulations. All promotional activities are exclusively directed toward qualified healthcare professionals and never to the general public.

We are committed to delivering scientifically robust, accurate, and balanced information regarding our products, including composition, mechanism of action, and clinical outcomes. Our practices are fully aligned with the standards of the European Medicines Agency (EMA) and applicable regulatory frameworks.

We support the medical community through:

  • Comprehensive clinical and scientific data
  • Disease-focused educational resources
  • Advanced training programs and scientific briefings
  • International congresses, symposia, and expert-led forums

Given the advanced and innovative nature of our portfolio, scientific rigor is central to all communications. Our Medical Division works in close partnership with Commercial teams to ensure the highest level of scientific accuracy, compliance, and credibility across all materials and engagements.